Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Systematic versus selective heparin use to prevent radial artery occlusion after catheterization

Official title: Comparaison d'un Traitement systématique à l'héparine Versus sélectif Pour la prévention de l'Occlusion Radiale EASY-Héparine

Run by Laval University · NCT06981624 · Data updated 2026-11-12

This test compares giving heparin to all patients versus only to selected patients to see which approach better prevents radial artery blockage after diagnostic transradial catheterization.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorLaval University
Academic / other
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedMay 13, 2025
Main results expectedAugust 2026
Study endsDecember 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT06981624 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults referred for diagnostic transradial catheterization who can provide informed consent and can receive antiplatelet therapy and intravenous anticoagulation are ideal candidates.

Probably not a fit

Patients who cannot consent, cannot receive antiplatelet or anticoagulant drugs, or who have local access complications such as hematoma or pseudoaneurysm are unlikely to be eligible or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults referred for diagnostic transradial catheterization are randomized to a routine (systematic) heparin strategy or an elective/selective heparin strategy, with hemostasis managed using a dual-artery compression system. The main outcome is occurrence of radial artery occlusion after the procedure. Patients who cannot consent or cannot receive required antiplatelet or anticoagulant medications are excluded. The trial is conducted at a single tertiary cardiac center with follow-up to document artery patency and immediate postprocedural complications.

Why it matters

Potential benefit: If successful, this approach could allow clinicians to avoid unnecessary heparin in some patients while preserving radial artery patency and reducing bleeding risk.

How similar studies have gone: Prior studies have shown routine periprocedural heparin reduces radial artery occlusion, while selective or no-heparin strategies have been less thoroughly tested in randomized comparisons.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any patient referred for a diagnostic transradial catheterism

Exclusion Criteria:

* Unable to understand study design or provide informed consent
* Unable to receive antiplatelet therapy with aspirina and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparine or bivalirudine
* Local condition such as hematoma or pseudo-aneurims precluding radial or ulnar access.
* Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression (due to colaterals or interouseous artery) precluding the evaluation of patent hemostasis.

Where it's running

  • Iucpq
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.